# BridgeBio Oncology Therapeutics, Inc.: Form SC 13D, filed Feb 20, 2024

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: SC 13D
- Filed: 2024-02-20
- Accepted by EDGAR: Feb 20, 2024, 19:48 ET
- Period: not reported
- Accession: 0001213900-24-015480
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000121390024015480/ea0200275-13dhelix2_helix2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000121390024015480/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000121390024015480/ea0200275-13dhelix2_helix2.htm

Filed Feb 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-015480. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.